Staring down huge pandemic inspection backlog, FDA lays out 'roadmap' to get back on track By Fraiser Kansteiner

 

Staring down huge pandemic inspection backlog, FDA lays out 'roadmap' to get back on track By Fraiser Kansteiner As the pandemic disrupted normal operations last year, the FDA accrued a massive backlog of facility inspections. Now, the agency is laying the groundwork to get its site reviews back on track.  Read More